Chembio Diagnostics Investor Relations Material

Latest events

Q3 2022

Chembio Diagnostics

Investor Presentation

2 Jan, 2023

Q3 2022

3 Nov, 2022
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Chembio Diagnostics Inc

Access all reports
Chembio is a leading point of care diagnostics company focused on detecting and diagnosing infectious diseases. Chembio Labs has evolved out of research at the Baylor College of Medicine, one of the world's top medical schools, and through collaborations with academia and industry leaders in developing innovative new diagnostic tests that can be used by physicians to make informed decisions about treatment options for patients.